News
06-24-2008, 04:23 AM
Breast cancer patients and their families might hold the important key to enabling new technologies that can help pinpoint the right treatment for the right patient at the right time. A new genomics project spearheaded by Santa Clara-based Iris BioTechnologies is looking for participants to offer information that will lead to more personalized medicine for the treatment of breast cancer and other deadly illnesses.
More... (http://www.medicalnewstoday.com/articles/112517.php)
More... (http://www.medicalnewstoday.com/articles/112517.php)